Tag:
Merck
Latest Headlines
Latest Headlines
JVs like Pfizer, Hisun hookup provide Chinese companies shot at Western markets
Joint ventures with Chinese companies have been seen as a way for Big Pharma to get better traction in the exploding China market. But it is not a one-way street. Chinese companies see the tie-ups as a way to build their own capabilities and begin to tap lucrative Western markets.
FDA: Merck's sleep drug suvorexant effective, but safety issues draw heavy flak
FDA staffers found clear evidence to prove that Merck's blockbuster drug candidate suvorexant is quite effective in promoting sleep, but the internal review cites multiple safety issues for the high doses studied in clinical trials.
Australian judge kills Merck Vioxx class action settlement
A federal judge in Australia has put the kibosh on a half-million-dollar settlement over ill effects of Merck's ($MRK) painkiller Vioxx, a drug that has spawned billions of dollars in litigation.
Daktari Diagnostics reels in $7M as it preps for Scotland expansion
Daktari Diagnostics reeled in another $7 million in equity financing, an amount likely to help fuel the company's overall expansion as well as the construction of a new plant in Scotland for its point-of-care-HIV tests.
Merck targets docs with revamped U.K. website and healthcare apps
Merck's U.K. group has raised its level of play in an industry-wide competition for the attention of physicians as they use the Internet.
Merck execs' bogeymen: Animal-rights, disease activists, plus laid-off workers
What keeps Merck's security staff up at night? Animal rights activists and laid-off workers, apparently.
HemCon, a struggling wound dressing device maker, is sold
A year after HemCon Medical Technologies filed for Chapter 11 reorganization following the loss of a patent fight, the Oregon maker of gels and dressings has been sold.
FDA accepts Merck's sublingual allergy med license application
Merck won the FDA's acceptance of a Biologics License Application for its investigational ragweed pollen allergy tablet to be delivered under the tongue.
Merck rep seeks $100M in sex-discrimination suit
Plaintiff Kelly Smith claimed Merck systematically discriminates against women and pregnant employees, even cutting the pay of managers whose subordinates take maternity leave.
GlaxoSmithKline, Merck offer GAVI 95% discount on HPV vaccines
GlaxoSmithKline and Merck are slashing the prices of their HPV vaccinations in a deal with the GAVI Alliance, which delivers immunizations to the developing world.
